Bernhard J. Lammers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Bernhard J. Lammers has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Peter E. Goretzki
Lukas-Krankenhaus-GmbH Neuss
5 shared publications Nicholas Bohnert
2 shared publicationsAndreas Baer
1 shared publicationAndreas Bär
1 shared publication- Aristotelis Touloumtzidis
Department of General Surgery, Städtisches Klinikum, Lukaskrankenhaus Neuss, Neuss, Germany,
1 shared publication Bernd Klosterhalfen
1 shared publication
Latest Publications
- 1 May 2015
- Vol. 26, 143-8
Resection of Ileoinguinal and Ileohypogastric Nerves Combined with Gluing in Modified Lichtenstein Repair.
We conducted a cohort trial to investigate the relevance of resection of the ilioinguinal and iliohypogastric nerves in combination with mesh fixation with BioGlue™ (CryoLife® Inc., Kennsaw, Georgia) in modified Lichtenstein repair to the development of chronic pain and hernia recurrence.1 In all, 430 patients underwent Lichtenstein repair. In 247 patients the mesh was fixed by means of glue, and in 183 patients it was fixed with conventional sutures. In all cases the inguinal nerves N. ilioinguinalis and N. iliohypogastricus were located and resected after identification to prevent nerve reaction to the mesh. The pain intensity was measured with a numeric analogous scale (NAS) 24 hours after surgery. All complications were recorded with a follow-up of up to 5 years. There was a significantly lower pain intensity level in the gluing group compared with the suture group 24 hours after surgery (0.016 t test). The level was 3.8±2.4 in bilateral hernia and 3.3±2.1 in unilateral hernia in the gluing group. It was 4.7±3.3 in unilateral and 3.7±2.2 in bilateral hernia in the suture group. The cut-suture time was lower in the gluing group. There were no severe pain syndromes (NAS≥4) in the gluing group and only 1.1% in the suture group. There was a higher incidence of non-bacterial wound infections in the gluing group (3.6%) than in the suture group (1.1%). The rate of recurrence after 5 years amounted to 2.0% in the gluing group and 2.2% in the suture group. The technique of using BioGlue™ for mesh fixation combined with systematic nerve dissection reduces acute and chronic postoperative pain after modified Lichtenstein repair. Only 2 of 430 patients suffered from severe chronic pain. Combined gluing and systematic resection of the inguinal nerves is more comfortable than standard Lichtenstein repair.
- 1 May 2015
- Vol. 26, 143-8
Resection of Ileoinguinal and Ileohypogastric Nerves Combined with Gluing in Modified Lichtenstein Repair.
We conducted a cohort trial to investigate the relevance of resection of the ilioinguinal and iliohypogastric nerves in combination with mesh fixation with BioGlue™ (CryoLife® Inc., Kennsaw, Georgia) in modified Lichtenstein repair to the development of chronic pain and hernia recurrence.1 In all, 430 patients underwent Lichtenstein repair. In 247 patients the mesh was fixed by means of glue, and in 183 patients it was fixed with conventional sutures. In all cases the inguinal nerves N. ilioinguinalis and N. iliohypogastricus were located and resected after identification to prevent nerve reaction to the mesh. The pain intensity was measured with a numeric analogous scale (NAS) 24 hours after surgery. All complications were recorded with a follow-up of up to 5 years. There was a significantly lower pain intensity level in the gluing group compared with the suture group 24 hours after surgery (0.016 t test). The level was 3.8±2.4 in bilateral hernia and 3.3±2.1 in unilateral hernia in the gluing group. It was 4.7±3.3 in unilateral and 3.7±2.2 in bilateral hernia in the suture group. The cut-suture time was lower in the gluing group. There were no severe pain syndromes (NAS≥4) in the gluing group and only 1.1% in the suture group. There was a higher incidence of non-bacterial wound infections in the gluing group (3.6%) than in the suture group (1.1%). The rate of recurrence after 5 years amounted to 2.0% in the gluing group and 2.2% in the suture group. The technique of using BioGlue™ for mesh fixation combined with systematic nerve dissection reduces acute and chronic postoperative pain after modified Lichtenstein repair. Only 2 of 430 patients suffered from severe chronic pain. Combined gluing and systematic resection of the inguinal nerves is more comfortable than standard Lichtenstein repair.
- 15 June 2012
- Published by Springer Nature
- p. 135-152
Surgery for Hyperthyroidism
- 1 December 2011
- Vol. 21, 21-7
Evaluation of Biocompatibility of Alloplastic Materials: Development of a Tissue Culture In Vitro Test System.
Optimized biocompatibility is a major requirement for alloplastic materials currently applied in surgical approaches for hernia, incontinence, and prolapse situations. Tissue ingrowth/adherence and formation of connective tissue seem to have important influence in mesh incorporation at the implant site. In an in vitro approach we randomly investigated 7 different mesh types currently used in surgeries with various indications with regard to their adherence performance. Using a tissue culture approach, meshes were incubated with tissue representative of fibroblasts, muscle cells, and endothelial cells originating from 10 different patients. After 6 weeks, the meshes were assessed microscopically and a ranking of their adherence performance was established. Tissue culture was successful in 100% of the probes. We did not remark on interindividual differences concerning the growth and adherence performance after incubation with the different meshes in the investigated 10 patients. The ranking was consistent in all patients. In this test system, PVDF Dynamesh® (FEG Textiltechnik, Aachen, Germany) was the mesh with the best growth-in score. The test system was feasible and reproducible. Pore size seems to be a predictor of adherence performance. The test system may be a helpful tool for further investigations, and the predictive value should be assessed in further in vitro and in vivo experiments.
- 1 December 2011
- Vol. 21, 21-7
Evaluation of Biocompatibility of Alloplastic Materials: Development of a Tissue Culture In Vitro Test System.
Optimized biocompatibility is a major requirement for alloplastic materials currently applied in surgical approaches for hernia, incontinence, and prolapse situations. Tissue ingrowth/adherence and formation of connective tissue seem to have important influence in mesh incorporation at the implant site. In an in vitro approach we randomly investigated 7 different mesh types currently used in surgeries with various indications with regard to their adherence performance. Using a tissue culture approach, meshes were incubated with tissue representative of fibroblasts, muscle cells, and endothelial cells originating from 10 different patients. After 6 weeks, the meshes were assessed microscopically and a ranking of their adherence performance was established. Tissue culture was successful in 100% of the probes. We did not remark on interindividual differences concerning the growth and adherence performance after incubation with the different meshes in the investigated 10 patients. The ranking was consistent in all patients. In this test system, PVDF Dynamesh® (FEG Textiltechnik, Aachen, Germany) was the mesh with the best growth-in score. The test system was feasible and reproducible. Pore size seems to be a predictor of adherence performance. The test system may be a helpful tool for further investigations, and the predictive value should be assessed in further in vitro and in vivo experiments.
- 1 October 2010
- Vol. 20, 115-23
Water-jet dissection in rectal cancer surgery: surgical and oncological outcomes.
These days the treatment of rectal cancer remains an encounter for various medical disciplines. A key position in the whole concept of therapy is still taken by surgery itself. To facilitate the advantages of the total mesorectal excision (TME) we used the water-jet dissector (WJD) in our surgical routine. Our object was to analyze perioperative data as well as oncological long-term results following WJD-assisted rectal resection. A total of 226 patients underwent surgery for rectal cancer in our center between October 2001 and June 2009. A retrospective review was performed of all WJD-assisted rectal resections during this time. One hundred and five patients with adenocarcinoma of the lower and middle rectum were operated on by 7 surgeons according to the concept of TME. Seventy-six patients underwent a low anterior resection, 29 patients an abdominoperineal resection. Twenty-eight patients received preoperative radiochemotherapy. The median follow-up period amounted to 35 (2-96) months. Survival rates were calculated using the Kaplan-Meier method. Anastomotic leakage occurred in 5.7%, wound healing disturbance (including perineal wound infections) in 29.5%, intra-abdominal infections in 7.6% and urinary tract infections in 7.6%. Postoperative bladder dysfunction (requiring catheterization) occurred in 1.9%. Postoperative 30-day mortality was 0%, 60-day mortality 1%. The rate of local recurrence (including three patients who refused postoperative radiochemotherapy) was 8.5%. Cancer-specific survival at 5 years was 74% and differed significantly by stage. The particular advance of the WJD is the facile development of the embryological plane between the mesorectal fascia and the surrounding pelvic nerves. Without harming one of them, maximum radicality and excellent autonomic nerve preservation can be achieved. The WJD is a technique with acceptable postoperative morbidity and low mortality. Local control and survival are comparable to other surgical centers in international literature.
- 1 October 2010
- Vol. 20, 115-23
Water-jet dissection in rectal cancer surgery: surgical and oncological outcomes.
These days the treatment of rectal cancer remains an encounter for various medical disciplines. A key position in the whole concept of therapy is still taken by surgery itself. To facilitate the advantages of the total mesorectal excision (TME) we used the water-jet dissector (WJD) in our surgical routine. Our object was to analyze perioperative data as well as oncological long-term results following WJD-assisted rectal resection. A total of 226 patients underwent surgery for rectal cancer in our center between October 2001 and June 2009. A retrospective review was performed of all WJD-assisted rectal resections during this time. One hundred and five patients with adenocarcinoma of the lower and middle rectum were operated on by 7 surgeons according to the concept of TME. Seventy-six patients underwent a low anterior resection, 29 patients an abdominoperineal resection. Twenty-eight patients received preoperative radiochemotherapy. The median follow-up period amounted to 35 (2-96) months. Survival rates were calculated using the Kaplan-Meier method. Anastomotic leakage occurred in 5.7%, wound healing disturbance (including perineal wound infections) in 29.5%, intra-abdominal infections in 7.6% and urinary tract infections in 7.6%. Postoperative bladder dysfunction (requiring catheterization) occurred in 1.9%. Postoperative 30-day mortality was 0%, 60-day mortality 1%. The rate of local recurrence (including three patients who refused postoperative radiochemotherapy) was 8.5%. Cancer-specific survival at 5 years was 74% and differed significantly by stage. The particular advance of the WJD is the facile development of the embryological plane between the mesorectal fascia and the surrounding pelvic nerves. Without harming one of them, maximum radicality and excellent autonomic nerve preservation can be achieved. The WJD is a technique with acceptable postoperative morbidity and low mortality. Local control and survival are comparable to other surgical centers in international literature.
- 1 April 2009
- Vol. 18, 125-8
Less pain intensity after lichtenstein-repair by using BioGlue™ for mesh fixation.
A pre-trial was conducted to investigate the reliability of using the surgical adhesive, BioGlue™ (CryoLife®, Inc., Kennesaw, Georgia, USA) for mesh fixation in Lichtenstein repair of inguinal hernia. From February to August 2008, 60 patients with unilateral inguinal hernia underwent a Lichtenstein repair. In 30 of the patients, BioGlue™ was used for mesh fixation and in the other 30 cases a conventional suture was used. The patients were sorted into two groups (BioGlue™-group and suture-group). No differences were noted in demographic characteristics. The main criteria for dropout were incarceration, relapse, operation, and/or scrotal hernia. Twenty-four hours postoperative, pain intensity was measured with a numeric analogous scale (NAS) that reached from 0 (no pain) to 10 (heavy pain). The pain intensity in the BioGlue™-group was 2.4 points and 4.3 points in the suture-group. The cut-suture time was 30 minutes in the BioGlue™-group and 56 minutes in the suture-group. In the first nine months, no relapses, no mesh infections, nor serom-formations were reported; however, one superficial wound infection did occur in the BioGlue™-group. Lichtenstein-repair using BioGlue™ for mesh-fixation is a safe, new method without early recurrences and less pain-intensity in relation to suture-supported Lichtenstein repair.
- 1 April 2009
- Vol. 18, 125-8
Less pain intensity after lichtenstein-repair by using BioGlue™ for mesh fixation.
A pre-trial was conducted to investigate the reliability of using the surgical adhesive, BioGlue™ (CryoLife®, Inc., Kennesaw, Georgia, USA) for mesh fixation in Lichtenstein repair of inguinal hernia. From February to August 2008, 60 patients with unilateral inguinal hernia underwent a Lichtenstein repair. In 30 of the patients, BioGlue™ was used for mesh fixation and in the other 30 cases a conventional suture was used. The patients were sorted into two groups (BioGlue™-group and suture-group). No differences were noted in demographic characteristics. The main criteria for dropout were incarceration, relapse, operation, and/or scrotal hernia. Twenty-four hours postoperative, pain intensity was measured with a numeric analogous scale (NAS) that reached from 0 (no pain) to 10 (heavy pain). The pain intensity in the BioGlue™-group was 2.4 points and 4.3 points in the suture-group. The cut-suture time was 30 minutes in the BioGlue™-group and 56 minutes in the suture-group. In the first nine months, no relapses, no mesh infections, nor serom-formations were reported; however, one superficial wound infection did occur in the BioGlue™-group. Lichtenstein-repair using BioGlue™ for mesh-fixation is a safe, new method without early recurrences and less pain-intensity in relation to suture-supported Lichtenstein repair.